375 related articles for article (PubMed ID: 15872323)
1. Percutaneous radiofrequency ablation of renal tumors: technique, complications, and outcomes.
Ahrar K; Matin S; Wood CG; Wallace MJ; Gupta S; Madoff DC; Rao S; Tannir NM; Jonasch E; Pisters LL; Rozner MA; Kennamer DL; Hicks ME
J Vasc Interv Radiol; 2005 May; 16(5):679-88. PubMed ID: 15872323
[TBL] [Abstract][Full Text] [Related]
2. Renal cell carcinoma: clinical experience and technical success with radio-frequency ablation of 42 tumors.
Gervais DA; McGovern FJ; Arellano RS; McDougal WS; Mueller PR
Radiology; 2003 Feb; 226(2):417-24. PubMed ID: 12563135
[TBL] [Abstract][Full Text] [Related]
3. Percutaneous radiofrequency ablation of renal tumors: midterm results in 16 patients.
Memarsadeghi M; Schmook T; Remzi M; Weber M; Pötscher G; Lammer J; Kettenbach J
Eur J Radiol; 2006 Aug; 59(2):183-9. PubMed ID: 16725292
[TBL] [Abstract][Full Text] [Related]
4. Image-Guided Percutaneous Radiofrequency Ablation of Central Renal Cell Carcinoma: Assessment of Clinical Efficacy and Safety in 31 Tumors.
Dai Y; Covarrubias D; Uppot R; Arellano RS
J Vasc Interv Radiol; 2017 Dec; 28(12):1643-1650. PubMed ID: 28673657
[TBL] [Abstract][Full Text] [Related]
5. CT-guided bipolar and multipolar radiofrequency ablation (RF ablation) of renal cell carcinoma: specific technical aspects and clinical results.
Sommer CM; Lemm G; Hohenstein E; Bellemann N; Stampfl U; Goezen AS; Rassweiler J; Kauczor HU; Radeleff BA; Pereira PL
Cardiovasc Intervent Radiol; 2013 Jun; 36(3):731-7. PubMed ID: 22926302
[TBL] [Abstract][Full Text] [Related]
6. Oncologic efficacy of CT-guided percutaneous radiofrequency ablation of renal cell carcinomas.
Zagoria RJ; Traver MA; Werle DM; Perini M; Hayasaka S; Clark PE
AJR Am J Roentgenol; 2007 Aug; 189(2):429-36. PubMed ID: 17646471
[TBL] [Abstract][Full Text] [Related]
7. Intermediate outcomes and predictors of efficacy in the radiofrequency ablation of 100 pathologically proven renal cell carcinomas.
McClure TD; Chow DS; Tan N; Sayre JA; Pantuck AJ; Raman SS
J Vasc Interv Radiol; 2014 Nov; 25(11):1682-8; quiz 1689. PubMed ID: 25081202
[TBL] [Abstract][Full Text] [Related]
8. Percutaneous radiofrequency ablation of sporadic Bosniak III or IV lesions: treatment techniques and short-term outcomes.
Park JJ; Park BK; Park SY; Kim CK
J Vasc Interv Radiol; 2015 Jan; 26(1):46-54. PubMed ID: 25446421
[TBL] [Abstract][Full Text] [Related]
9. Percutaneous radiofrequency thermal ablation of renal cell carcinoma: is it possible a day-hospital treatment?
Carrafiello G; Laganà D; Ianniello A; Mangini M; Fontana F; Cotta E; Concollato L; Marconi A; Recaldini C; Dionigi G; Rovera F; Boni L; Cuffari S; Fugazzola C
Int J Surg; 2008; 6 Suppl 1():S31-5. PubMed ID: 19200792
[TBL] [Abstract][Full Text] [Related]
10. Imaging-guided percutaneous radiofrequency ablation of solid renal masses: techniques and outcomes of 38 treatment sessions in 32 consecutive patients.
Mayo-Smith WW; Dupuy DE; Parikh PM; Pezzullo JA; Cronan JJ
AJR Am J Roentgenol; 2003 Jun; 180(6):1503-8. PubMed ID: 12760909
[TBL] [Abstract][Full Text] [Related]
11. Improved outcome with combined US/CT guidance as compared to US guidance in percutaneous radiofrequency ablation of small renal masses.
Andersson M; Hashimi F; Lyrdal D; Lundstam S; Hellström M
Acta Radiol; 2015 Dec; 56(12):1519-26. PubMed ID: 25414370
[TBL] [Abstract][Full Text] [Related]
12. Renal tumors: technical success and early clinical experience with radiofrequency ablation of 18 tumors.
Sabharwal R; Vladica P
Cardiovasc Intervent Radiol; 2006; 29(2):202-9. PubMed ID: 16447001
[TBL] [Abstract][Full Text] [Related]
13. Chyluria after radiofrequency ablation of renal tumors.
Kaur H; Matin SF; Javadi S; Johnson VE; Choi H; Sandler C; Ahrar K
J Vasc Interv Radiol; 2011 Jul; 22(7):924-7. PubMed ID: 21507680
[TBL] [Abstract][Full Text] [Related]
14. Percutaneous microwave ablation of T1a and T1b renal cell carcinoma: short-term efficacy and complications with emphasis on tumor complexity and single session treatment.
Wells SA; Wheeler KM; Mithqal A; Patel MS; Brace CL; Schenkman NS
Abdom Radiol (NY); 2016 Jun; 41(6):1203-11. PubMed ID: 27167230
[TBL] [Abstract][Full Text] [Related]
15. Percutaneous cryoablation of anterior renal masses: technique, efficacy, and safety.
Schmit GD; Atwell TD; Leibovich BC; Callstrom MR; Kurup AN; Woodrum DA; Charboneau JW
AJR Am J Roentgenol; 2010 Dec; 195(6):1418-22. PubMed ID: 21098204
[TBL] [Abstract][Full Text] [Related]
16. Radiofrequency ablation of small renal cell carcinomas using multitined expandable electrodes: preliminary experience.
Clark TW; Malkowicz B; Stavropoulos SW; Sanchez R; Soulen MC; Itkin M; Patel A; Mondschein JI; Wein AJ
J Vasc Interv Radiol; 2006 Mar; 17(3):513-9. PubMed ID: 16567676
[TBL] [Abstract][Full Text] [Related]
17. Percutaneous Image-Guided Thermal Ablation for Multifocal Renal Cell Carcinoma: 10-Year Experience at a Single Center.
Zhou W; Uppot RN; Feldman AS; Arellano RS
AJR Am J Roentgenol; 2017 Oct; 209(4):733-739. PubMed ID: 28678572
[TBL] [Abstract][Full Text] [Related]
18. Adrenal neoplasms: CT-guided radiofrequency ablation--preliminary results.
Mayo-Smith WW; Dupuy DE
Radiology; 2004 Apr; 231(1):225-30. PubMed ID: 14990812
[TBL] [Abstract][Full Text] [Related]
19. Protecting the ureter during radiofrequency ablation of renal cell cancer: a pilot study of retrograde pyeloperfusion with cooled dextrose 5% in water.
Cantwell CP; Wah TM; Gervais DA; Eisner BH; Arellano R; Uppot RN; Samir AE; Irving HC; McGovern F; Mueller PR
J Vasc Interv Radiol; 2008 Jul; 19(7):1034-40. PubMed ID: 18589317
[TBL] [Abstract][Full Text] [Related]
20. Application of contrast-enhanced ultrasonography after radiofrequency ablation for renal cell carcinoma: is it sufficient for assessment of therapeutic response?
Kong WT; Zhang WW; Guo HQ; Qiu JL; Tang M; Jiang ZM; Shen Y; Li XG; Zhang SW
Abdom Imaging; 2011 Jun; 36(3):342-7. PubMed ID: 21107560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
